- VSTM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Verastem (VSTM) 8-K23 Jan 25Delivering Novel Therapies for RAS/MAPK Pathway Driven Cancers January 2025 Corporate PresentationFinancial data
Company Profile